第41届欧洲泌尿外科协会年会 (EAU26) 将于2026年3月13日-16日召开。在尿路上皮癌（膀胱癌及上尿路尿路上皮癌 UTUC）领域，中国专家的研究覆盖了疾病的全周期管理。从非肌层浸润性膀胱癌（NMIBC）的卡介苗（BCG）替代治疗方案，到肌层浸润性膀胱癌（MIBC）的保膀胱综合治疗；从国产ADC药物（如RC48）的联合应用，到上尿路尿路上皮癌（UTUC）的精准预后模型。中国团队在探索适合中国患者的诊疗模式的同时，也为国际尿路上皮癌的治疗格局带来了新的启示。【肿瘤资讯】特将摘要标题进行整理，以飨读者。
摘要号：A0074
Title：Phase 1/2 study of an anti-PD-L1/IL-15 variant fusion protein (SIM0237) in BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC)
讲者：叶定伟教授
单位：复旦大学附属肿瘤医院
摘要号：A0075
Title：Intravesical versus intravenous therapy of Camrelizumab in BCG-unresponsive high-risk non--muscle-invasive bladder cancer: Results from a randomized parallel-cohort phase I--II study
讲者：Shen Yi Jun
单位：复旦大学附属肿瘤医院
摘要号：A0078
Title：Omitting Pelvic Lymph Node Dissection during Radical Cystectomy for NMIBC: An Interim Analysis of a Prospective, Multicenter, Randomized Trial
讲者：Lyu Qiang
单位：南京医科大学第一附属医院
摘要号：A0085
Title：Single-Center Prospective Study of Transurethral Cystoscopic Bladder Tumor Resection with Ultrasonic Scalpel Under CO₂ Pneumovesicum: Report on Technical Feasibility and Preliminary Efficacy
讲者：Yang Shujun
单位：中国人民解放军总医院
摘要号：A0090
Title：Disitamab Vedotin Alone or Combined with PD-1 Inhibitors in High-Risk Non--Muscle-Invasive Bladder Cancer: A Multicenter Real-World Study
讲者：Guo Xuanjun
单位：北京大学第一医院
摘要号：A0127
Title：Gut Microbiome Shapes the Tumour Immune Microenvironment and Predicts Benefit to RC-48 plus Tislelizumab in Urothelial Bladder Cancer: A Multicentre Cohort with Translational Validation
讲者：Cheng Bisheng
单位：南方医科大学南方医院
摘要号：A0381
Title：Intratumoral Microbiome Programs the Immune Microenvironment and Predicts Response to Intravesical BCG in NMIBC
讲者：Cheng Bisheng
单位：南方医科大学附属南方医院
摘要号：A0382
Title：SLBP-mediated remodeling of the immunosuppressive microenvironment as a potential therapeutic target: Insights from multi-omics analyses
讲者：Zhang Qi
单位：广州医科大学附属第一医院
摘要号：A0383
Title：Entinostat Overcomes Cisplatin Resistance in Bladder Cancer by Promoting H3K18la-Mediated DHRS2 Expression to Suppress the AKR1C3-Androgen Axis
讲者：Xu Guanghui
单位：南京大学医学院附属鼓楼医院
摘要号：A0570
Title：Predictable Patterns of Lymph Node Metastasis in Upper Tract Urothelial Carcinoma: Implications for Surgical Planning
讲者：Jianjun Ye
单位：四川大学华西医院
摘要号：A0577
Title：Development and validation of DNA Methylation-Based machine-learning models to guide adjuvant therapy in nonmetastatic high risk upper tract urothelial carcinoma: A multicenter, bidirectional cohort study.
讲者：Fu Shufan
单位：北京大学第一医院
摘要号：A0578
Title：Adjuvant Radiotherapy Combined Immunotherapy and Lymphovascular Invasion Associate With Better Disease-free Survival of Locally Progressive Upper Tract Urothelial Carcinoma
讲者：Xu Chunru
单位：北京大学第一医院
摘要号：A0579
Title：Efficacy and safety of disitamab vedotin (DV) combined with tislelizumab as adjuvant therapy after radical surgery for patients with HER2-expression upper tract urothelial carcinoma (UTUC): a prospective, controlled, phase II study
讲者：顾良友
单位：中国人民解放军总医院
摘要号：A0580
Title：Preliminary results of a phase II study to evaluate the efficacy and safety of disitamab vedotin (RC48-ADC) in combination with radiotherapy for adjuvant therapy in upper tract urothelial carcinoma
讲者：Tao Zihao
单位：北京大学第一医院
摘要号：A0581
Title：Peritumoral tertiary lymphoid structures foster potent antitumor immunity and predict clinical outcomes in upper tract urothelial carcinoma
讲者：Huang Yiwei
单位：北京大学第一医院
摘要号：A0582
Title：Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma (CURATE-UTUC): A Multicenter Prospective Longitudinal Cohort Study
讲者：黄吉炜
单位：上海交通大学医学院附属仁济医院
摘要号：A0589
Title：Establishment and Multidimensional Validation of a Rapid Drug Screening Platform Using a Patient-Derived Zebrafish Xenograft Model of Upper Tract Urothelial Carcinoma
讲者：Long Xuezhi
单位：广州医科大学附属第一医院
摘要号：A0590
Title：Development and validation of a DNA methylation risk score system for prognosis stratification in urothelial carcinoma
讲者：Fu Shufan
单位：北京大学第一医院
摘要号：A0621
Title：bp-VI-RADS Combined with Normalized ADC Enhances Diagnostic Efficacy for Muscle-Invasive Bladder Cancer
讲者：Yang Rong
单位：南京大学医学院附属鼓楼医院
摘要号：A0623
Title：Comparison of Diagnostic Efficacy Between Post-Treatment VI-RADS Based on Biparametric MRI and Multiparametric MRI in Assessing Residual Tumor and Muscle Invasion After Treatment for Bladder Cancer
讲者：Lyu Qiang
单位：南京医科大学第一附属医院
摘要号：A0653
Title：A Phase III, Randomized, Open-Label Trial of Disitamab Vedotin (DV) Plus Bacillus Calmette--Guérin (BCG) in BCG-Naïve Patients with HER2-Expressing High-Risk Non--Muscle Invasive Bladder Cancer(HERO)
讲者：Shen Yi Jun
单位：复旦大学附属肿瘤医院
摘要号：A0762
Title：Perioperative Disitamab Vedotin and Tislelizumab Followed by Nephron-Sparing Surgery in High-Risk Upper Tract Urothelial Carcinoma: A Phase 2 Trial (DISTINCT-I)
讲者：黄吉炜
单位：上海交通大学医学院附属仁济医院
摘要号：A0767
Title：Anatomical refinement matters: Ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy
讲者：Bao Guan
单位：北京大学第一医院
摘要号：A0769
Title：A preoperative nomogram for predicting postoperative renal function decline after radical nephroureterectomy: Guiding neoadjuvant chemotherapy decisions in upper tract urothelial carcinoma
讲者：Hong Peng
单位：北京大学第三医院
摘要号：A0773
Title：Synergistic impact of LRRC15⁺ stroma and CD163⁺ macrophage infiltration on metastasis in upper tract urothelial carcinoma
讲者：Lo Chien-Hsiung（中国台湾）
单位：国立成功大学医学部附设医院
摘要号：A0776
Title：FGFR3 and TERT Mutations Associate with Distinct Clinicopathological Features and Prognosis in Upper Tract and Bladder Urothelial Carcinoma
讲者：Xiong Yujia
单位：四川大学华西医院
摘要号：A0778
Title：Clinical Link Between Renal Interstitial Fibrosis and Tumor Stroma Activation in Predicting Metastasis of Upper Tract Urothelial Carcinoma
讲者：Lo Chien-Hsiung（中国台湾）
单位：国立成功大学医学部附设医院
摘要号：A0824
Title：Nectin4-Targeted Fluorescence Imaging for Enhanced TURBT: From Preclinical Validation to First-in-Human Application
讲者：He Yuhui
单位：中日友好医院
摘要号：A0855
Title：Efficacy and Safety of a Novel Treatment Scheme of RC48-ADC Plus PD-1 Inhibitors in Metastatic Urothelial Carcinoma: A Multicenter Real-world Study
讲者：lin jun
单位：福建医科大学附属协和医院
摘要号：A0857
Title：The comparison of CT and MRI based Node-RADS in predicting lymph node metastasis bladder cancer
讲者：Yang Xiao
单位：南京医科大学第一附属医院
摘要号：A0858
Title：A non-invasive preoperative fusion model for predicting lymph node metastasis in bladder cancer: a multicenter study
讲者：Yang Xiao
单位：南京医科大学第一附属医院
摘要号：A0864
Title：Noninvasive Evaluation of HER2 Expression AND Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT
讲者：Tao Zihao
单位：北京大学第一医院
摘要号：A0869
Title：Efficacy of RC48-ADC in combination with toripalimab in patients with HER2-positive muscle-invasive urothelial bladder cancer and the prospect of bladder preservation
讲者：Li Chenglong
单位：武汉市人民医院
摘要号：A0877
Title：Final results of a multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive bladder cancer（Hope-03）
讲者：张朋教授
单位：四川大学华西医院
本文内容截至2026年2月3日官网最新情况，如有错漏之处，敬请留言补充！
https://scientific-programme.uroweb.org/EAU26/programme
排版编辑：肿瘤资讯-明小丽
苏公网安备32059002004080号
